Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX

Summary

The primary objective of this trial is to examine the value of prophylactic versus therapeutic breast radiotherapy in Casodex monotherapy induced gynaecomastia and/or breast pain. Patients will receive either prophylactic radiotherapy to the breast at a dose of 12Gy (as two fractions of 6 Gy in consecutives days), or will not receive any radiotherapy prior to commencing CASODEX 150mg monotherapy.

Timeline

Start

2003-06

Primary completion

—

Completion

—

Drugs

Indications